Acral Lentiginous Melanoma (ALM) is a rare type of skin cancer that typically appears on the palms, soles, or under the nails. It is a subtype of melanoma, which is a cancer that develops from the pigment-producing cells known as melanocytes. Stage 3 indicates that the cancer has spread to nearby lymph nodes but not to distant organs.
Presentation
Patients with Acral Lentiginous Melanoma often notice a dark spot or patch on the skin that may change in size, shape, or color. It can appear as a flat or slightly raised discolored area with irregular borders. In some cases, it may resemble a bruise or a streak under a nail. Symptoms may include itching, tenderness, or bleeding.
Workup
Diagnosing ALM involves a thorough physical examination and a biopsy of the suspicious lesion. A biopsy involves removing a small sample of tissue for microscopic examination. Imaging tests such as CT scans, MRIs, or PET scans may be used to determine if the cancer has spread to lymph nodes or other parts of the body. Sentinel lymph node biopsy is often performed to check for cancer spread.
Treatment
Treatment for Stage 3 Acral Lentiginous Melanoma typically involves surgical removal of the tumor and affected lymph nodes. Additional treatments may include immunotherapy, which uses the body's immune system to fight cancer, or targeted therapy, which uses drugs to target specific cancer cells. Radiation therapy may also be considered in certain cases.
Prognosis
The prognosis for Stage 3 ALM varies depending on several factors, including the size and location of the tumor, the number of affected lymph nodes, and the patient's overall health. While Stage 3 indicates a more advanced cancer, treatment advancements have improved outcomes. Regular follow-up is crucial to monitor for recurrence or spread.
Etiology
The exact cause of Acral Lentiginous Melanoma is not well understood. Unlike other types of melanoma, ALM is not strongly linked to sun exposure. Genetic factors may play a role, and it is more common in individuals with darker skin tones. Mutations in certain genes, such as KIT, have been associated with ALM.
Epidemiology
Acral Lentiginous Melanoma is relatively rare, accounting for a small percentage of all melanoma cases. It is the most common type of melanoma in people with darker skin, including African, Asian, and Hispanic populations. It can occur at any age but is more frequently diagnosed in older adults.
Pathophysiology
ALM arises from melanocytes located in the acral skin, which covers the palms, soles, and nail beds. The cancerous cells grow and invade surrounding tissues, and in Stage 3, they spread to nearby lymph nodes. The biological behavior of ALM is similar to other melanomas, but its unique location and presentation can delay diagnosis.
Prevention
Preventing Acral Lentiginous Melanoma involves regular skin examinations to detect changes early. Individuals should be aware of any new or changing lesions on their palms, soles, or nails. While sun protection is less relevant for ALM, maintaining overall skin health and monitoring for unusual changes is important.
Summary
Acral Lentiginous Melanoma is a rare form of skin cancer that appears on the palms, soles, or under the nails. Stage 3 indicates lymph node involvement. Diagnosis involves biopsy and imaging, while treatment includes surgery and possibly additional therapies. Prognosis depends on various factors, and regular monitoring is essential.
Patient Information
If you notice a dark spot or streak on your palms, soles, or nails that changes in appearance, it is important to seek medical evaluation. Early detection and treatment of Acral Lentiginous Melanoma can improve outcomes. Regular skin checks and awareness of changes are key to managing your skin health.